A meta-analysis of immune-related adverse events via anti- Programmed Death 1 treatment in malignant tumors [report]

Yixin Cui, Yin Zhang, Decai Wang, Jiwei Mi, Haiming Wang, Gege Chen, Shaodan Li
2021 unpublished
INTRODUCTION Review question / Objective: The aim of this meta-analysis is to investigate the immune-related adverse events via anti-P ro g r a m m e d D e a t h 1 t re a t m e n t i n malignant tumors. Condition being studied: Due to the significant impact of anti-PD-1 treatment on improving the survival of several advanced cancers, the use of it will be inevitably increased in the future. It is imperative to identify the incidence and characteristics of irAEs in malignant tumors after
more » ... umors after anti-PD-1 treatment. Here, we INPLASY 1 International Platform of Registered Systematic Review and Meta-analysis Protocols Review question / Objective: The aim of this meta-analysis is to investigate the immune-related adverse events via anti-Programmed Death 1 treatment in malignant tumors. Condition being studied: Due to the significant impact of anti-PD-1 treatment on improving the survival of several advanced cancers, the use of it will be inevitably increased in the future. It is imperative to identify the incidence and characteristics of irAEs in malignant tumors after anti-PD-1 treatment. Here, we plan to conduct a meta-analysis to investigate the incidence of irAEs via anti-PD-1 treatment in malignant tumors. INPLASY registration number: This protocol was registered with the International
doi:10.37766/inplasy2021.1.0091 fatcat:5254sle26bh2ngamh7hwlyo6s4